squamous-cell-carcinoma

Documents about squamous-cell-carcinoma

• Oncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After Anti-PD(L)1#303732ClinicalTrials.gov
• Chemoradiotherapy versus radiotherapy alone in the management of early-stage anal squamous cell carcinoma: A comparative analysis of the French cohort FFCD-ANABASE#326105HAL (France)
• Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitors#460978HAL (France)
• A Phase II Trial for MOR Antagonism With Axelopran to Enhance Immunotherapy in Head and Neck Cancer#463721ClinicalTrials.gov
• Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia#802300ClinicalTrials.gov
• The Efficacy of Induction and Adjuvant Camrelizumab Combined With Chemoradiation for LA-HNSCC#804516ClinicalTrials.gov
• Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer#841543ClinicalTrials.gov
• FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel#873596ClinicalTrials.gov
• Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by Surgery#878803ClinicalTrials.gov
• LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy#835566ClinicalTrials.gov
• Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer#868770ClinicalTrials.gov
• Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer#804686ClinicalTrials.gov
• Phase II Trial of Allovectin-7® for Head and Neck Cancer#857005ClinicalTrials.gov
• A Study to Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid Tumors#826788ClinicalTrials.gov
• Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer#891336ClinicalTrials.gov
• Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer#892026ClinicalTrials.gov
• Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer#805396ClinicalTrials.gov
• A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies#353286ClinicalTrials.gov
• A Comparison of Skin Grafts Versus Local Flaps for Facial Skin Cancer From the Patient Perspective: A Feasibility Study#853002ClinicalTrials.gov
• the Study of Effect of Chronomodulated Chemotherapy on the Dendritic Cells Subsets in the Treatment of Advanced Nasopharyngeal Cancer#877487ClinicalTrials.gov
• Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.#172326ClinicalTrials.gov
• Maintenance Immune Check-point Inhibitor Following Post-operative Chemo-radiation in Subjects With HPV-negative HNSCC#195323ClinicalTrials.gov
• Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN#332739ClinicalTrials.gov
• Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project#468338HAL (France)
• Phase 2 Study of Imprime PGG & Pembrolizumab in Subjects With Adv SCCHN Who Failed Pembro Monotherapy or Experiencing SD#804781ClinicalTrials.gov
• A Phase Ⅱ Trials of Sintilimab as Consolidation Therapy After Radical Concurrent Chemoradiotherapy in Locally Advanced Unresectable ESCC#824772ClinicalTrials.gov
• Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC#849286ClinicalTrials.gov
• ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma#869896ClinicalTrials.gov
• Comparison of Nab-Paclitaxel Versus Paclitaxel in Neoadjuvant Immunochemotherapy Therapy for Esophageal Squamous Cell Carcinoma: A Retrospective IPTW-Adjusted Analysis#877474ClinicalTrials.gov
• A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers#803305ClinicalTrials.gov
• Phase I Study of the Combination of Afatinib and Ruxolitinib in Patients With Treatment-refractory Non-Small Cell Lung Cancer (NSCLC)#873250ClinicalTrials.gov
• A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies#830569ClinicalTrials.gov
• PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCC#272395ClinicalTrials.gov
• Phase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 With Pembrolizumab Before Standard Treatment in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal Cancer#314395ClinicalTrials.gov
• The impact of margins in laryngeal cancer patients treated with transoral laser microsurgery: a systematic review and meta-analysis#430384IRIS
• Early Tumor Shrinkage and Clinical Outcomes for Esophageal Squamous Cell Carcinoma Patients Treated with Immune Checkpoint Inhibitors: Real-World Observational Study#439915Springer Nature OA
• Frailty and Overall Survival of Older Patients Undergoing Radiotherapy for Head and Neck Cancer: A Prospective Analysis#644178IRIS
• Efficacy and Safety Study of Bevacizumab Plus Chemotherapy in EGFR-TKI Resistant Non-Squamous Non-Small Cell Lung Cancer#805388ClinicalTrials.gov
• Smoking Tobacco Cessation Integrated Program of Patients Treated for the Head and the Neck Cancer#831438ClinicalTrials.gov
• Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCC#838625ClinicalTrials.gov
• Phase II Trial of HM781-36B in Patients With Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) After Failure of or Unfit for Platinum-containing Therapy#867175ClinicalTrials.gov
• Group-Mediated Cognitive Behavioral Resistance Exercise Intervention in Head and Neck Cancer Patients Undergoing Chemoradiation Treatment#891518ClinicalTrials.gov
• Irinotecan Study For Cervical Cancer#892404ClinicalTrials.gov
• Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations#854723ClinicalTrials.gov
• Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)#872189ClinicalTrials.gov
• HERC1 oncogene enhances stemness and tumorigenic potential in CD44^+-derived organoids of head and neck squamous cell carcinoma through IL-6/STAT3 signaling#153880Springer Nature OA
• Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors#332761ClinicalTrials.gov
• GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors#889624ClinicalTrials.gov
• Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery#847548ClinicalTrials.gov
• A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC)#828994ClinicalTrials.gov